当前位置:首页 - 行情中心 - 莱茵生物(002166) - 财务分析 - 现金流量表

莱茵生物

(002166)

  

流通市值:57.37亿  总市值:57.77亿
流通股本:7.36亿   总股本:7.42亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,486,182,916.971,056,035,394.49594,106,387.961,888,280,454.12
  收到的税费返还23,862,794.4120,626,504.666,313,359.9570,908,816.45
  收到其他与经营活动有关的现金8,684,811.596,048,776.053,670,545.8722,652,318
  经营活动现金流入小计1,518,730,522.971,082,710,675.2604,090,293.781,981,841,588.57
  购买商品、接受劳务支付的现金912,762,861.02603,291,753.05326,250,630.191,415,577,326.37
  支付给职工以及为职工支付的现金149,746,011.16104,261,122.7657,265,330.15185,707,033.63
  支付的各项税费41,928,622.3134,739,231.0617,422,333.6753,134,538.18
  支付其他与经营活动有关的现金67,835,326.2545,641,368.2620,215,885.78167,709,093.35
  经营活动现金流出小计1,172,272,820.74787,933,475.13421,154,179.791,822,127,991.53
  经营活动产生的现金流量净额346,457,702.23294,777,200.07182,936,113.99159,713,597.04
二、投资活动产生的现金流量:
  收回投资收到的现金998,683.5380,839.5236,454.084,124,071.86
  取得投资收益收到的现金4,403,059.6315,047.83-7,362,916.2
  处置固定资产、无形资产和其他长期资产收回的现金净额136,830.2104,348103,348109,030
  投资活动现金流入小计5,538,573.33500,235.35139,802.0811,596,018.06
  购建固定资产、无形资产和其他长期资产支付的现金120,246,861.4885,226,314.7253,324,549.53207,081,135.72
  投资活动现金流出小计120,246,861.4885,226,314.7253,324,549.53207,081,135.72
  投资活动产生的现金流量净额-114,708,288.15-84,726,079.37-53,184,747.45-195,485,117.66
三、筹资活动产生的现金流量:
  取得借款收到的现金789,848,408.5503,848,408.5291,889,156.5942,894,636
  收到其他与筹资活动有关的现金12,600,000-5,099,252319,100,000
  筹资活动现金流入小计802,448,408.5503,848,408.5296,988,408.51,261,994,636
  偿还债务支付的现金789,440,092.5500,010,092.5211,020,092.5703,570,255
  分配股利、利润或偿付利息支付的现金103,919,944.5693,938,443.5811,355,735.38190,320,195.79
  支付其他与筹资活动有关的现金53,188,616.4847,245,130.9246,523,380.21397,863,799.92
  筹资活动现金流出小计946,548,653.54641,193,667268,899,208.091,291,754,250.71
  筹资活动产生的现金流量净额-144,100,245.04-137,345,258.528,089,200.41-29,759,614.71
四、汇率变动对现金及现金等价物的影响1,492,697.061,563,464.92882,805.761,636,118.97
五、现金及现金等价物净增加额89,141,866.174,269,327.12158,723,372.71-63,895,016.36
  加:期初现金及现金等价物余额49,769,406.3549,769,406.3549,769,406.35113,664,422.71
  期末现金及现金等价物余额138,911,272.45124,038,733.47208,492,779.0649,769,406.35
补充资料:
  净利润-43,672,421.11-167,173,992.57
  资产减值准备-422,147.6-21,463,296.06
  固定资产和投资性房地产折旧-60,963,155.65-94,197,003.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-60,963,155.65-94,197,003.43
  无形资产摊销-2,514,229.17-4,589,958.37
  长期待摊费用摊销-565,772.46-4,253,880.75
  处置固定资产、无形资产和其他长期资产的损失-109,497.53-523,831.47
  固定资产报废损失-942,659.52-1,116,976.43
  公允价值变动损失-207,129.89--2,025,062.21
  财务费用-19,396,828.1-41,281,141.03
  投资损失--74,624.01--7,178,829
  递延所得税-2,321,545.33-951,847.94
  其中:递延所得税资产减少-872,809.53--2,820,177.9
    递延所得税负债增加-1,448,735.8-3,772,025.84
  存货的减少-30,610,947.13--237,129,675
  经营性应收项目的减少-172,473,105.21-8,251,296.59
  经营性应付项目的增加--39,426,464.42-42,370,133.3
  其他--1,590,905.19-16,076,345.8
  现金的期末余额-124,038,733.47-49,769,406.35
  减:现金的期初余额-49,769,406.35-113,664,422.71
  现金及现金等价物的净增加额-74,269,327.12--63,895,016.36
公告日期2025-10-282025-08-292025-04-262025-03-28
审计意见(境内)标准无保留意见
TOP↑